IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,615.43 ▲ 0.39% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL5.11▲ 0.19% USD/MXN17.53▲ 0.59% USD/CLP931.20▲ 0.67% USD/COP3,251▲ 0.61% USD/PEN3.39▲ 0.21% USD/ARS1,478▲ 0.17% USD/UYU40.23▲ 1.74% USD/PYG6,032▲ 1.81% USD/BOB10.65▲ 4.37% USD/DOP58.24▲ 1.37% USD/CRC446.12▲ 1.44% USD/GTQ7.62▲ 2.73% USD/HNL26.73▲ 1.94% USD/NIO36.62▲ 0.34% USD/VES730.65▲ 0.57% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 0.87% USD/TTD6.74▲ 1.70% EUR/BRL5.84▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.49% GOLD 4,019 ▲ 0.83% SILVER 56.33 ▲ 0.77% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 304.70 ▼ 5.17% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,753 ▲ 10.30% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.63% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 64,450 ▲ 0.86% ETH 1,855 ▲ 0.78% SOL 75.19 ▲ 0.24% XRP 1.09 ▲ 0.10% BNB 570.61 ▲ 0.50% ADA 0.17 ▼ 0.93% DOGE 0.07 ▼ 0.30% AVAX 6.56 ▼ 0.30% LINK 8.31 ▲ 0.60% DOT 0.83 ▼ 1.64% LTC 47.16 ▲ 4.47% BCH 220.41 ▲ 0.31% TRX 0.33 ▲ 0.78% XLM 0.19 ▲ 0.72% HBAR 0.07 ▲ 1.12% NEAR 1.93 ▲ 0.23% ATOM 1.50 ▼ 0.83% AAVE 89.30 ▼ 0.73% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07% EGX 52,928 ▲ 0.70% USD/ZAR16.48— 0.00% USD/NGN1,378▼ 0.20% NIKKEI 64,141 ▼ 4.03% CSI300 4,529 ▼ 3.60% HSI 24,562 ▼ 1.78% NIFTY 24,334 ▲ 1.09% KOSPI 6,821 ▼ 6.37% JCI 6,176 ▲ 1.10% USD/JPY162.35▼ 0.03% USD/CNY6.77▼ 0.12% DAX 24,831 ▼ 0.34% CAC 8,339 ▼ 0.47% FTSE 10,600 ▲ 0.27% MIB 51,882 ▼ 0.94% IBEX 19,217 ▼ 0.45% STOXX 641.53 ▼ 0.34% EUR/USD1.14▲ 0.04% GBP/USD1.35▼ 0.66% SPX 7,458 ▼ 1.01% DJI 52,146 ▼ 0.77% NDX 28,593 ▼ 1.49% RUT 2,962 ▼ 0.42% TSX 35,264 ▼ 0.22% VIX 18.77 ▲ 12.19% USD/CAD1.40— 0.00% US10Y 4.5410 ▼ 0.61% IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,615.43 ▲ 0.39% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL 5.11 ▲ 0.19% USD/MXN 17.53 ▲ 0.59% USD/CLP 931.20 ▲ 0.67% USD/COP 3,251 ▲ 0.61% USD/PEN 3.39 ▲ 0.21% USD/ARS 1,478 ▲ 0.17% USD/UYU 40.23 ▲ 1.74% USD/PYG 6,032 ▲ 1.81% USD/BOB 10.65 ▲ 4.37% USD/DOP 58.24 ▲ 1.37% USD/CRC 446.12 ▲ 1.44% USD/GTQ 7.62 ▲ 2.73% USD/HNL 26.73 ▲ 1.94% USD/NIO 36.62 ▲ 0.34% USD/VES 730.65 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 0.36% USD/TTD 6.74 ▲ 1.17% EUR/BRL 5.84 ▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.49% GOLD 4,019 ▲ 0.83% SILVER 56.33 ▲ 0.77% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 304.70 ▼ 5.17% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,753 ▲ 10.30% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.63% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 64,450 ▲ 0.86% ETH 1,855 ▲ 0.78% SOL 75.19 ▲ 0.24% XRP 1.09 ▲ 0.10% BNB 570.61 ▲ 0.50% ADA 0.17 ▼ 0.93% DOGE 0.07 ▼ 0.30% AVAX 6.56 ▼ 0.30% LINK 8.31 ▲ 0.60% DOT 0.83 ▼ 1.64% LTC 47.16 ▲ 4.47% BCH 220.41 ▲ 0.31% TRX 0.33 ▲ 0.78% XLM 0.19 ▲ 0.72% HBAR 0.07 ▲ 1.12% NEAR 1.93 ▲ 0.23% ATOM 1.50 ▼ 0.83% AAVE 89.30 ▼ 0.73% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07% EGX 52,928 ▲ 0.70% USD/ZAR 16.48 ▲ 0.63% USD/NGN 1,378 ▲ 0.02% NIKKEI 64,141 ▼ 4.03% CSI300 4,529 ▼ 3.60% HSI 24,562 ▼ 1.78% NIFTY 24,334 ▲ 1.09% KOSPI 6,821 ▼ 6.37% JCI 6,176 ▲ 1.10% USD/JPY 162.35 ▲ 0.01% USD/CNY 6.7677 ▲ 0.07% DAX 24,831 ▼ 0.34% CAC 8,339 ▼ 0.47% FTSE 10,600 ▲ 0.27% MIB 51,882 ▼ 0.94% IBEX 19,217 ▼ 0.45% STOXX 641.53 ▼ 0.34% EUR/USD 1.1446 ▲ 0.02% GBP/USD 1.3452 ▼ 0.21% SPX 7,458 ▼ 1.01% DJI 52,146 ▼ 0.77% NDX 28,593 ▼ 1.49% RUT 2,962 ▼ 0.42% TSX 35,264 ▼ 0.22% VIX 18.77 ▲ 12.19% USD/CAD 1.4020 ▼ 0.14% US10Y 4.5410 ▼ 0.61%
since 2009
Saturday, July 18, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (October 19)

By · November 8, 2021 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database for reporting vaccine adverse events, had collected 28,103 reports of deaths and 2,637,525 reports of injuries (half of them serious) from people who had received any of the four experimental injections currently licensed in EU member states as of October 19. A previous report, dated August 28, counted 24,526 deaths and 2,317,495 injuries.

EudraVigilance was launched in 2012 by the European Medicines Agency to provide public access to reports of suspected adverse reactions. These reports are submitted electronically to EudraVigilance by national drug regulatory authorities and pharmaceutical companies with marketing authorizations for the drugs.

Their report lists 28,103 deaths and 2,637,525 injuries following injections with any of the four currently approved experimental “vaccines” through October 19, 2021.

MODERNA – COVID-19 mRNA VACCINE (CX-024414)
PFIZER-BioNTech – COVID-19 mRNA VACCINE
ASTRAZENECA COVID-19 VACCINE (CHADOX1 NCOV-19)
COVID-19 JANSSEN VACCINE (AD26.COV2.S )

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

Of the total number of injuries recorded, nearly half (1,249,109) are severe injuries*.

*According to Eudravigilance, “Severity provides information about the suspected adverse effect; it may be classified as ‘serious’ if it is a medical event that results in death, is life-threatening, requires hospitalization, results in another medically critical condition, or prolongs an existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly/defect.

As noted in previous reports, we owe the following information to a subscriber to the Health Impact News website in Europe who took the trouble to add detail to the reports on each of the four COVID-19 injections listed here. This subscriber volunteered to do this. It is a lot of work to tabulate each response with injuries and deaths, as there is no space in the EudraVigilance system to tabulate all outcomes.

It should be noted that not all reported deaths and injuries are necessarily related to vaccination. These reports are known to be a tiny fraction of actual cases, as most deaths and injuries are not reported.

We again recommend reading the analysis (in French, please use online translator) of Laurent Mucchielli, Director of Research at the French National Center for Scientific Research (CNRS), who reviewed several databases of adverse event reports for COVID vaccines worldwide and finally issued a direct warning to all: “We are facing unprecedented mortality, and a moratorium on vaccination must be imposed.”

SUMMARIZED DATA EUDRAVIGILANCE AS PER OCTOBER 19, 2021

Total reactions for Pfizer/BioNTech’s vaccine:

13,271 deaths and 1,168,872 injuries.

As of 19/10/2021

  • 31,537 Blood and lymphatic system diseases, incl. 183 deaths
  • 33,677 Heart disease, incl. 1,958 deaths
  • 312 Congenital, familial, and genetic disorders, incl. 25 deaths
  • 16,024 Hearing and labyrinth disorders, including 10 deaths
  • 1,012 Endocrine disorders incl. 5 deaths
  • 18,146 Eye disorders, including 30 deaths
  • 100,624 Gastrointestinal disorders incl. 541 deaths
  • 301,622 General diseases and diseases at the site of administration incl. 3,778 deaths
  • 1337 Hepatobiliary diseases incl. 64 deaths
  • 11,765 Immune system diseases incl. 65 deaths
  • 43,138 Infections and infectious diseases, including 1340 deaths
  • 15,919 Injuries, poisonings, and procedural complications, including 208 deaths
  • 29,450 investigations, including 418 deaths
  • 8,182 Metabolic and nutritional disorders incl. 236 deaths
  • 149,865 Musculoskeletal and connective tissue disorders incl. 163 deaths
  • 983 Benign, malignant, and unspecified neoplasms (incl. cysts and polyps) incl. 95 deaths
  • 202,217 Diseases of the nervous system incl. 1,430 deaths
  • 1,587 Pregnancy, puerperium, and perinatal diseases incl. 46 deaths
  • 185 Product expenditures incl. 2 deaths
  • 21,513 Psychiatric disorders incl. 168 deaths
  • 4,061 Renal and urinary diseases incl. 212 deaths
  • 33,753 Reproductive system and breast diseases incl. 4 deaths
  • 50,834 Respiratory, thoracic, and mediastinal diseases incl. 1,551 deaths
  • 55,669 Diseases of the skin and subcutaneous tissue, including 118 deaths
  • 2,332 Social circumstances, including 18 deaths
  • 1,760 Medical and surgical procedures incl. 36 deaths
  • 31,368 Vascular diseases incl. 567 deaths

Total reactions to Moderna vaccine

7,543 deaths and 341,634 injuries

as of 19/10/2021

  • 6,923 Blood and lymphatic system diseases, including 78 deaths
  • 10,706 Heart disease, including 811 deaths
  • 137 Congenital, familial, and genetic disorders, including 4 deaths
  • 4,229 Hearing and labyrinth disorders, including 1 death
  • 290 Endocrine disorders incl. 3 deaths
  • 5,154 Eye disorders incl. 23 deaths
  • 28,856 Gastrointestinal disorders incl. 294 deaths
  • 91,974 General diseases and diseases at the site of administration incl. 2,764 deaths
  • 561 Hepatobiliary diseases incl. 30 deaths
  • 2,909 Immune system disorders, including 11 deaths
  • 11,413 Infections and infectious diseases, including 596 deaths
  • 7,377 Injuries, poisonings, and procedural complications, including 141 deaths
  • 6,389 investigations, including 132 deaths
  • 3,271 metabolic and nutritional disorders, including 171 deaths
  • 42,103 Musculoskeletal and connective tissue disorders incl. 155 deaths
  • 431 Benign, malignant, and unspecified neoplasms (incl. cysts and polyps) incl. 52 deaths
  • 58,789 Diseases of the nervous system, including 758 deaths
  • 648 Pregnancy, puerperium, and perinatal disorders, including 8 deaths
  • 66 Product problems, including 2 deaths
  • 6,354 Psychiatric disorders, including 132 deaths
  • 1,971 Kidney and urinary tract disorders incl. 137 deaths
  • 6,174 Reproductive system and breast diseases, including 6 deaths
  • 15,051 respiratory, thoracic, and mediastinal diseases, incl. 780 deaths
  • 18,450 Skin and subcutaneous tissue disorders, including 66 deaths
  • 1,553 Social circumstances, including 28 deaths
  • 1,187 Medical and surgical procedures incl. 75 deaths
  • 8,668 Vascular diseases incl. 285 deaths

Total responses for Oxford/AstraZeneca vaccine:

5,767 deaths and 1,039,136 injuries

As of 19/10/2021

  • 12,601 Blood and lymphatic system diseases, including 236 deaths
  • 18,113 Heart disease, including 659 deaths
  • 175 Familial congenital and genetic disorders, including 7 deaths
  • 12,248 Hearing and labyrinth disorders, including 1 deaths
  • 557 Endocrine disorders incl. 4 death
  • 18,324 Eye disorders incl. 28 deaths
  • 100,110 Gastrointestinal disorders incl. 300 deaths
  • 273,678 General diseases and diseases at the site of administration, including 1376 deaths
  • 908 Hepatobiliary diseases incl. 54 deaths
  • 4,241 Immune system disorders, including 26 deaths
  • 29,229 Infections and infectious diseases, including 367 deaths
  • 11,837 Poisonings from injuries and procedural complications, including 166 deaths
  • 22,810 investigations, including 137 deaths
  • 12,087 Metabolic and nutritional disorders incl. 88 deaths
  • 155,324 Musculoskeletal and connective tissue disorders incl. 85 deaths
  • 570 Benign, malignant, and unspecified neoplasms (incl. cysts and polyps) incl. 20 deaths
  • 215,104 Diseases of the nervous system incl. 900 deaths
  • 490 Pregnancy, puerperium, and perinatal diseases incl. 11 deaths
  • 177 Product expenditures incl. 1 death
  • 19,380 Psychiatric disorders incl. 57 deaths
  • 3,911 Renal and urinary diseases incl. 55 deaths
  • 14,363 Reproductive system and breast diseases incl. 2 deaths
  • 36,720 Respiratory, thoracic, and mediastinal diseases incl. 691 deaths
  • 47,763 Skin and subcutaneous tissue diseases, including 43 deaths1,391 Social circumstances, including 6 deaths
  • 1,273 Medical and surgical procedures incl. 24 deaths
  • 25,752 Vascular diseases incl. 423 deaths

Total responses for Johnson & Johnson vaccine:

1,522 deaths and 87,883 injuries

as of 19/10/2021

  • 824 Blood and lymphatic system diseases, incl. 35 deaths
  • 1,512 Heart disease, incl. 141 deaths
  • 31 Congenital, familial and genetic disorders
  • 865 Hearing and labyrinth disorders, incl. 1 deaths
  • 54 Endocrine disorders incl. 1 death
  • 1,188 Eye disorders incl. 6 deaths
  • 7,668 Gastrointestinal disorders incl. 66 deaths
  • 22,981 General and administrative disorders incl. 408 deaths
  • 108 Hepatobiliary diseases incl. 9 deaths
  • 364 Diseases of the immune system incl. 7 deaths
  • 2,933 Infections and infectious diseases, including 107 deaths
  • 816 Injuries, poisonings and procedural complications, including 16 deaths
  • 4,359 investigations, including 90 deaths
  • 531 metabolic and nutritional disorders, including 36 deaths
  • 13,245 Musculoskeletal and connective tissue disorders, including 34 deaths
  • 46 Benign, malignant, and unspecified neoplasms (including cysts and polyps), including 2 deaths
  • 17,645 Diseases of the nervous system, including 165 deaths
  • 33 Pregnancy, puerperium, and perinatal diseases, including 1 death
  • 22 problems with the product
  • 1,208 Psychiatric disorders, including 13 deaths
  • 345 Kidney and urinary tract diseases incl. 17 deaths
  • 1,544 Reproductive system and breast disorders incl. 6 deaths
  • 3,133 Respiratory, thoracic, and mediastinal disorders, including 176 deaths
  • 2,708 Skin and subcutaneous tissue diseases, including 6 deaths
  • 276 Social circumstances including 4 deaths
  • 630 Medical and surgical procedures incl. 46 deaths
  • 2,814 Vascular diseases incl. 129 deaths

 

 

 

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.